![Nathan Stasko](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Nathan Stasko was the founder of NVN Liquidation, Inc. since 2006, serving as President, Director & Chief Scientific Officer from 2017 to 2019.
Dr. Stasko is currently the Chief Executive Officer & Director at Vast Therapeutics, Inc. since 2022.
Formerly, Dr. Stasko was a Director at KNOW Bio LLC.
Posizioni attive di Nathan Stasko
| Società | Posizione | Inizio |
|---|---|---|
Vast Therapeutics, Inc.
 Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical stage biotechnology company which develops inhalable therapeutics to treat chronic infections | Amministratore Delegato | 01/03/2022 |
Precedenti posizioni note di Nathan Stasko
| Società | Posizione | Fine |
|---|---|---|
| NVN LIQUIDATION, INC. | Amministratore Delegato | 05/06/2017 |
KNOW Bio LLC
 KNOW Bio LLC Pharmaceuticals: MajorHealth Technology Develops and produces nitric oxide-based therapies | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
24
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
NVN Liquidation, Inc.
 NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
KNOW Bio LLC
KNOW Bio LLC Pharmaceuticals: MajorHealth Technology Develops and produces nitric oxide-based therapies | Health Technology |
Vast Therapeutics, Inc.
Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical stage biotechnology company which develops inhalable therapeutics to treat chronic infections | Health Technology |
